DGAP-Adhoc: ProSiebenSat.1 Media SE: Dr. Andreas Wiele to become Chairman of the Supervisory Board
2021. december 06., hétfő, 20:13
DGAP-Ad-hoc: ProSiebenSat.1 Media SE / Key word(s): Personnel - Chairman of the Supervisory Board Dr. Werner Brandt will not stand for re-election after two election periods at the Annual General Meeting to be held in May 2022 - Dr. Andreas Wiele already appointed by Court as successor to Adam Cahan effective February 13, 2022 Munich, December 6, 2021. The Chairman of the Supervisory Board of ProSiebenSat.1 Media SE, Dr. Werner Brandt (67), has decided not to stand for re-election to the Supervisory Board at the Annual General Meeting on May 5, 2022 after eight years and two election periods. The Supervisory Board intends to elect Dr. Andreas Wiele (59), formerly a member of the Executive Board of Axel Springer SE and a proven transformation expert, at the upcoming Annual General Meeting as its new Chairman and thus as Dr. Brandt"s successor. This was decided by Dr. Brandt and the Supervisory Board in a Supervisory Board meeting today. Dr. Wiele will be a court-appointed member of the Supervisory Board from February 13, 2022. He succeeds Adam Cahan (49), who has resigned from the Supervisory Board to take up a new role as CEO of PAX Labs, Inc., a technology company in California. The Supervisory Board plans to recommend confirming the appointment of Dr. Wiele at the Annual General Meeting. He would then be elected as successor to Dr. Brandt in the Chairman position. Contact: Stefanie Rupp-Menedetter Head of Group Communications & Events ProSiebenSat.1 Media SE Medienallee 7 · D-85774 Unterföhring Tel. +49 89 950 725 98 Mobil +49 17 283 527 03 Stefanie.Rupp@prosiebensat1.com
|
Language: | English |
Company: | ProSiebenSat.1 Media SE |
Medienallee 7 | |
85774 Unterföhring | |
Germany | |
Phone: | +49 (0)89 9507-1463 |
Fax: | +49 (0)89 9507-91463 |
E-mail: | Dirk.Voigtlaender@ProSiebenSat1.com |
Internet: | www.prosiebensat1.com |
ISIN: | DE000PSM7770 |
WKN: | 777117 |
Indices: | MDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Luxembourg Stock Exchange |
EQS News ID: | 1254611 |
End of Announcement | DGAP News Service |
1254611 06-Dec-2021 CET/CEST
Közzétételek - archívum
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. Enters into Strategic Partnership with U.S.-Israeli Cannabis Innovation Lab
[2020.07.22. 15:00]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. and Greek Joint Venture Partner to Launch "Cannamo(TM)" Brand of CBD Pet Products
[2020.07.08. 17:15]